Overview

Detailed Summary

Trimurthi Limited, originally a financial and securities company, transitioned into pharmaceuticals and drugs, marking significant industry diversification.
The company operates pharmacy retail outlets in Hyderabad and has expanded its operations in West Bengal and Assam, indicating a strategic geographic expansion in India.
Trimurthi Limited has also commenced operations in the food industry through a wholly-owned subsidiary, signaling diversification beyond pharmaceuticals.
The company received ISO 9001:2008 certification, demonstrating a commitment to quality in its pharmaceutical marketing and distribution processes.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Market Cap: 59 Cr
Volatility: Low Risk
P/E Ratio: -63.8
Industry P/E: 28.9
PEG Ratio: —
P/B Ratio: 3.2
52W High: 70.16
52W Low: 26.61

Sales CAGR

1Y: -7.09%
3Y: 231.51%
5Y: 97.11%
10Y: 47.49%

Profit CAGR

1Y: 46.01%
3Y: —
5Y: -2.28%
10Y: -1.66%

ROE

TTM: -30.18%
3Y: 0.11%
5Y: -9.96%
10Y: -3.75%

ROCE

TTM: -32.45%
3Y: 0.27%
5Y: -9.88%
10Y: -3.58%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ONYX	34.20	62 Cr	10.33	1.11	0.00	1.95	4.14	1.16
PHRMASI	89.50	61 Cr	3.44	9.40	0.00	7.28	7.84	40.10
VIVIMEDLAB	7.10	59 Cr	-1.89	0.00	0.00	50.81	-2.49	-2.64
TRIMURTHI	57.85	59 Cr	-63.85	3.24	0.00	-30.18	-32.45	-30.18
VINEETLAB	30.21	58 Cr	-5.72	1.31	0.00	-117.41	-22.41	-11.20
MANGALAM	32.00	50 Cr	-1.64	0.42	0.00	-15.52	-2.61	-9.77
RAJNISH	0.48	49 Cr	-27.32	0.45	0.00	-0.10	0.05	-0.90

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022
Sales	2.05	2.48	2.19	2.51	4.35	2.46	1.11	0.69	1.36	1.24
Expenses	2.20	2.63	2.44	5.76	4.51	2.31	2.05	2.32	1.50	1.42
Operating Profit	-0.17	-0.17	-0.26	-3.26	-0.16	0.15	-0.94	-1.63	-0.14	-0.18
OPM %	-8.29	-6.85	-11.87	-129.88	-3.68	6.10	-84.68	-236.23	-10.29	-14.52
Other Income	0.12	0.07	0.11	0.03	0.17	0.33	0.03	0.12	0.08	0.05
Interest	0.02	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.05	0.03	0.08	0.06	0.05	0.04	0.04	-0.03	0.02	0.02
Profit Before Tax	-0.10	-0.13	-0.23	-3.29	-0.04	0.44	-0.95	-1.48	-0.09	-0.15
Tax %	10.00	-23.08	0.00	0.00	-75.00	20.45	22.11	-6.08	0.00	0.00
Net Profit	-0.09	-0.15	-0.23	-3.29	-0.07	0.35	-0.74	-1.57	-0.09	-0.15
EPS in Rs	-0.04	-0.09	-0.11	-1.65	-0.07	0.16	-0.31	-0.68	-0.04	-0.08

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Sales	5.96	5.77	6.35	5.72	9.19	11	9.89	10	9.24	8.61
Expenses	5.14	4.86	5.67	5.17	8.92	11	11	11	13	11
Operating Profit	0.81	0.90	0.68	0.55	0.22	-0.17	-0.86	-0.62	-3.86	-2.57
OPM %	13.57	15.69	10.67	9.63	2.35	-1.58	-8.73	-6.10	-41.79	-29.89
Other Income	0.01	0.02	0.00	0.13	0.17	0.21	0.95	0.60	0.32	0.64
Interest	0.01	0.01	0.00	0.00	0.05	0.16	0.13	0.11	0.06	0.00
Depreciation	0.27	0.29	0.41	0.35	0.19	0.24	0.21	0.19	0.21	0.10
Profit Before Tax	0.55	0.64	0.27	0.33	0.19	-0.20	-0.12	-0.21	-3.75	-2.03
Tax %	31.04	31.73	47.71	33.61	82.75	-71.70	-19.23	-20.53	-0.37	0.38
Net Profit	0.38	0.43	0.14	0.13	0.03	-0.35	-0.15	-0.26	-3.76	-2.03
EPS in Rs	—	-1.11	0.23	0.03	-0.01	—	-0.12	-0.14	-1.88	-0.91
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Equity Capital	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10	8.10
Reserves	2.93	3.37	3.33	3.45	3.44	3.07	2.82	2.50	-1.24	-0.70
Borrowings	0.04	0.01	0.00	0.00	0.96	0.98	0.93	0.77	0.00	0.13
Other Liabilities	0.47	0.73	1.08	1.18	1.25	1.44	1.49	2.35	2.71	1.20
Total Liabilities	12	12	13	13	14	14	13	14	9.57	8.74
Fixed Assets	1.22	1.17	0.75	0.70	2.10	2.17	1.92	1.83	1,653	0.47
CWIP	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.63	0.49	0.30	0.39	0.42
Other Assets	10	11	12	12	12	11	11	12	-1,644	7.85
Total Assets	12	12	13	13	14	14	13	14	9.57	8.74

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity	-3.45	-0.03	-0.84	2.05	-1.82	0.37	-0.53	0.63	1.59	1.59
Cash from Investing Activity	1.06	0.80	-0.25	-1.06	0.21	-0.64	0.43	0.45	0.14	-0.76
Cash from Financing Activity	2.41	0.19	-0.01	0.22	0.77	0.02	-0.05	-0.16	-0.77	0.00
Net Cash Flow	0.01	0.96	-1.11	1.22	-0.84	-0.24	-0.15	0.92	0.96	0.83

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Aug 2025	Sep 2025	Nov 2025	Dec 2025	Jan 2026	Feb 2026
Promoters	66.92%	66.54%	66.56%	66.56%	66.56%	52.75%	53.33%	53.33%	54.82%	51.98%	51.98%	46.51%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	33.08%	33.46%	33.44%	33.44%	33.44%	47.25%	46.67%	46.67%	45.18%	48.02%	48.02%	53.49%
Total Shareholders	2,635	2,569	2,533	2,502	2,484	2,481	2,754	2,697	2,770	2,994	2,994	3,029

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Novelix Pharmaceuticals Ltd

Novelix Pharmaceuticals Ltd (TRIMURTHI) is currently trading at 56.83 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Trimurthi Limited, originally a financial and securities company, transitioned into pharmaceuticals and drugs, marking significant industry diversification. The company operates pharmacy retail outlets in Hyderabad and has expanded its operations in West Bengal and Assam, indicating a strategic geographic expansion in India. Trimurthi Limited has also commenced operations in the food industry through a wholly-owned subsidiary, signaling diversification beyond pharmaceuticals. The company received ISO 9001:2008 certification, demonstrating a commitment to quality in its pharmaceutical marketing and distribution processes.

Over the past 52 weeks, Novelix Pharmaceuticals Ltd has traded between a low of ₹26.61 and a high of ₹70.16. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Novelix Pharmaceuticals Ltd has a market capitalization of approximately 58.64. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Novelix Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -63.85 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 58.64 Cr, Novelix Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Novelix Pharmaceuticals Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Novelix Pharmaceuticals Ltd is -63.85. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Novelix Pharmaceuticals Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Novelix Pharmaceuticals Ltd

What is Novelix Pharmaceuticals Ltd share price today?

What does Novelix Pharmaceuticals Ltd do?

What is the 52-week high and low of Novelix Pharmaceuticals Ltd?

What is the market capitalization of Novelix Pharmaceuticals Ltd?

Should I consider investing in Novelix Pharmaceuticals Ltd stock?

Is Novelix Pharmaceuticals Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Novelix Pharmaceuticals Ltd belong to and why does it matter?

What is the PE ratio of Novelix Pharmaceuticals Ltd?

Investor’s Suite

Screeners

Market Pulse

Deep Dive

Utility

Company

Technicals

Frequently Asked Questions about Novelix Pharmaceuticals Ltd

What is Novelix Pharmaceuticals Ltd share price today?

What does Novelix Pharmaceuticals Ltd do?

What is the 52-week high and low of Novelix Pharmaceuticals Ltd?

What is the market capitalization of Novelix Pharmaceuticals Ltd?

Should I consider investing in Novelix Pharmaceuticals Ltd stock?

Is Novelix Pharmaceuticals Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Novelix Pharmaceuticals Ltd belong to and why does it matter?

What is the PE ratio of Novelix Pharmaceuticals Ltd?

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Announcements

Overview

Financial Ratios

Investment Checklist